SVE
ENG
Menu
Search for:
Search
About us
The Company in Brief
Vision
Mission
History
Organisation
Collaborations and Partnerships
Our Science
Resolving Inflammation
The Melanocortin System and Inflammation
SynAct’s Technology – Selective Melanocortin Stimulation
Scientific Advisory Board
Pipeline
Pipeline Overview
The resomelagon (AP1189) Development Program
Rheumatoid Arthritis
Membranous Nephropathy
Virus Induced Respiratory Insufficiency
Peptide Agonists
TXP-11
Investors
Capital Markets Day 2024
Investment highlights
Word from the CEO
Financial Reports
Presentations
The Share
Share price development
Ownership Structure
Insiders
Share Capital Development
Analyst Coverage
Calendar
Press Releases
Prospectus and rights issues
2024
2023
2022
Older
Governance
General Meetings
Corporate Governance Report
Nomination Committee
Board of Directors
Remuneration Committee
Audit Committee
Management
Auditor
Articles of Association
Code of Conduct
Media
Press Releases
Synact in Media
Image Bank
Subscribe
Contact
Search for:
Search
Search for:
Search
Search results
Sorry, but nothing matched your search criteria. Please try again with some different keywords.